Current Value of Holding

$720 Million

Shares

9.78 Million

% of Portfolio

0.30%

Average Buy Price

$80.3

Avg closing price
Price range

23 Ken Fisher Edwards Lifesciences Trades

Ken Fisher's position in Edwards Lifesciences is currently worth $720 Million. That's 0.30% of their equity portfolio (76th largest holding). The investor owns 1.67% of the outstanding Edwards Lifesciences stock. The first Edwards Lifesciences trade was made in Q2 2019. Since then Ken Fisher bought shares nineteen more times and sold shares on three occasions. The investor's estimated purchase price is $785 Million, resulting in a loss of 8.2%.

Avg closing price
Price range
Increased shares by 7.7% (+697 Thousand shares) Q4 2024
Avg closing price $70.20
Price range $64.54 - $75.92
Increased shares by 9.8% (+807 Thousand shares) Q3 2024
Avg closing price $72.89
Price range $59.70 - $93.78
Increased shares by 8.5% (+645 Thousand shares) Q2 2024
Avg closing price $88.55
Price range $84.30 - $94.31
Increased shares by 7.0% (+499 Thousand shares) Q1 2024
Avg closing price $84.00
Price range $72.54 - $95.56
Sold 2.5% shares (-186 Thousand shares) Q4 2023
Avg closing price $69.58
Price range $61.71 - $77.76
Sold 8.8% shares (-703 Thousand shares) Q3 2023
Avg closing price $80.36
Price range $69.28 - $93.38
Increased shares by 2.5% (+198 Thousand shares) Q2 2023
Avg closing price $86.92
Price range $81.41 - $94.33
Increased shares by 1.9% (+147 Thousand shares) Q1 2023
Avg closing price $78.60
Price range $74.27 - $84.51
Increased shares by 1.8% (+134 Thousand shares) Q4 2022
Avg closing price $77.07
Price range $68.54 - $87.44
Increased shares by 2.8% (+208 Thousand shares) Q3 2022
Avg closing price $96.22
Price range $82.37 - $107.29
Increased shares by 3.2% (+228 Thousand shares) Q2 2022
Avg closing price $103.52
Price range $86.50 - $128.27
Increased shares by 4.7% (+321 Thousand shares) Q1 2022
Avg closing price $112.18
Price range $101.96 - $128.34
Increased shares by 5.6% (+358 Thousand shares) Q4 2021
Avg closing price $116.64
Price range $106.37 - $130.68
Increased shares by 4.3% (+267 Thousand shares) Q3 2021
Avg closing price $114.14
Price range $102.91 - $122.75
Increased shares by 5.7% (+335 Thousand shares) Q2 2021
Avg closing price $94.26
Price range $83.84 - $104.76
Increased shares by 4.4% (+244 Thousand shares) Q1 2021
Avg closing price $84.54
Price range $78.68 - $90.67
Increased shares by 7.4% (+386 Thousand shares) Q4 2020
Avg closing price $82.95
Price range $71.69 - $91.23
Increased shares by 4.1% (+205 Thousand shares) Q3 2020
Avg closing price $78.03
Price range $67.19 - $87.44
Increased shares by 22.7% (+923 Thousand shares) Q2 2020
Avg closing price $71.07
Price range $57.54 - $76.95
Increased shares by 17004.8% (+4.04 Million shares) Q1 2020
Avg closing price $72.12
Price range $52.41 - $81.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!